Position
SIMPLEX TRADING, LLC in CytomX Therapeutics, Inc.
Back to the book · All holders of CTMX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $10.6K$4.26 → $4.70
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 24.1K | $102.5K | — | — | — | 0.0% |
| Q1 2026 | 248.4K | $1.17M | $4.70 | $10.6K | $1.05M | 0.0% |